Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia

NCT03156842 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension
Dyslipidemia

Interventions

DRUG: Fimasartan/Amlodipine, Rosuvastatin
DRUG: Fimasartan/Amlodipine
DRUG: Fimasartan, Rosuvastatin

Sponsor

Boryung Pharmaceutical Co., Ltd